Other equities research analysts have also recently issued reports about the stock. Deutsche Bank lifted their price objective on shares of Perrigo from $88.00 to $95.00 and gave the company a buy rating in a research note on Thursday, September 14th. Canaccord Genuity set a $100.00 price objective on shares of Perrigo and gave the company a buy rating in a research note on Tuesday, December 26th. Argus upgraded shares of Perrigo from a hold rating to a buy rating and set a $93.00 price objective on the stock in a research note on Friday, December 8th. UBS Group restated a buy rating and set a $98.00 price objective (up from $84.00) on shares of Perrigo in a research note on Thursday, October 5th. Finally, Oppenheimer started coverage on shares of Perrigo in a research note on Monday, October 2nd. They set a buy rating and a $88.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has an average rating of Hold and a consensus price target of $92.00.
Shares of Perrigo (PRGO) opened at $91.80 on Friday. Perrigo has a one year low of $63.68 and a one year high of $92.75. The company has a current ratio of 1.72, a quick ratio of 1.24 and a debt-to-equity ratio of 0.54. The firm has a market cap of $12,930.00, a PE ratio of -10.02, a P/E/G ratio of 1.94 and a beta of 0.64.
Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Thursday, November 9th. The company reported $1.39 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.28. Perrigo had a negative net margin of 26.28% and a positive return on equity of 11.60%. The business had revenue of $1.22 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same period in the previous year, the business earned $1.65 earnings per share. The company’s revenue was down 2.0% on a year-over-year basis. research analysts predict that Perrigo will post 4.88 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 19th. Shareholders of record on Friday, December 1st were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $0.64 annualized dividend and a yield of 0.70%. Perrigo’s payout ratio is presently -6.99%.
In other Perrigo news, EVP John Wesolowski sold 388 shares of the business’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $87.20, for a total transaction of $33,833.60. Following the sale, the executive vice president now owns 248 shares in the company, valued at approximately $21,625.60. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Todd W. Kingma sold 1,500 shares of the business’s stock in a transaction dated Thursday, December 28th. The stock was sold at an average price of $88.52, for a total value of $132,780.00. Following the sale, the vice president now owns 19,565 shares in the company, valued at approximately $1,731,893.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,051 shares of company stock worth $355,370. Corporate insiders own 6.90% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the business. State Street Corp raised its holdings in Perrigo by 1.7% during the 2nd quarter. State Street Corp now owns 6,757,086 shares of the company’s stock worth $510,294,000 after buying an additional 112,287 shares during the period. Sei Investments Co. raised its holdings in Perrigo by 7.5% during the 3rd quarter. Sei Investments Co. now owns 131,284 shares of the company’s stock worth $11,114,000 after buying an additional 9,192 shares during the period. Cetera Advisors LLC acquired a new stake in Perrigo during the 3rd quarter worth about $398,000. Andra AP fonden raised its holdings in Perrigo by 9.9% during the 3rd quarter. Andra AP fonden now owns 16,700 shares of the company’s stock worth $1,414,000 after buying an additional 1,500 shares during the period. Finally, Howard Hughes Medical Institute acquired a new stake in Perrigo during the 2nd quarter worth about $778,000. Hedge funds and other institutional investors own 83.22% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This report was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://transcriptdaily.com/2018/01/16/perrigo-prgo-given-a-107-00-price-target-by-cantor-fitzgerald-analysts.html.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.